Neuroprotective strategy for Alzheimer disease: Intranasal administration of a fatty neuropeptide

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 1, 1996, Pages 427-432

  Gozes, I ^a   Bardea, A ^a   Reshef, A ^a   Zamostiano, R ^a   Zhukovsky, S ^a   Rubinraut, S ^b   Fridkin, M ^b   Brenneman, D E ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; ETHYLCHOLINE MUSTARD AZIRIDINIUM; NEUROPEPTIDE; SECRETIN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE DERIVATIVE; VASOACTIVE INTESTINAL POLYPEPTIDE[17 STEARYLNORLEUCINE];

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN PROTECTION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFICACY; DRUG POTENCY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LEARNING; LIPOPHILICITY; MALE; MEMORY; NERVE CELL CULTURE; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RAT;

ADMINISTRATION, INTRANASAL; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; AZIRIDINES; CELL DEATH; CELLS, CULTURED; CHOLINE; LEARNING; LIPIDS; MALE; MEMORY; NEUROMUSCULAR BLOCKING AGENTS; NEURONS; PARASYMPATHOLYTICS; RATS; RATS, WISTAR; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0030052889     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.1.427     Document Type: Article

References (49)

1. Shapira, J. (1994) J. Gerontol. Nurs. 20, 4-9.
2. Brumback, R. A. & Leech, R. W. (1994) J. Okla. State Med. Assoc. 87, 103-111.
3. Kowall, N. W., Beal, M. F., Buscigilio, J., Duffy, L. K. & Yankner, B. A. (1991) Proc. Natl. Acad. Sci. USA 88, 7247-7251.
4. Selkoe, D. J. (1993) Trends Neurosci. 16, 403-409.
5. Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D. & Roses, A. D. (1993) Proc. Natl. Acad. Sci. USA 90, 9649-9653.
6. Koliatsos, V. E., Price, D. L., Clatterbuck, R. E., Markowska, A. L., Olton, D. S. & Wilcox, B. J. (1993) Ann. N.Y. Acad. Sci. 695, 292-299.
7. Price, D. L., Koliatsos, V. E., Sisodia, S. S., Koo, E. H., Martin, L. J., Walker, L. C., Applegate, M. D. & Cork, L. C. (1991) Clin. Neuropharmacol. 14, Suppl. 1, S9-14.
8. Nitsch, R. M., Slack, B. E., Wurtman, R. J. & Growdon, J. H. (1992) Science 258, 304-307.
9. Fisher, A., Brandeis, R., Pittel, Z., Karton, I., Sapir, M., Dachir, S., Levy, A. & Heldman, E. (1989) Neurosci. Lett. 102, 325-331.
10. Gaspar, E., Heeringa, M., Markel, E., Luitan, P. G. M. & Nyakas, C. (1991) Brain Res. Bull. 28, 65-71.
11. Dong, X. W., Hanin, I. & Loren, S. A. (1994) Brain Res. Bull. 35, 217-220.
12. Nordberg, A., Lilja, A., Lundqvist, H., Hartvig, P., Amberla, K., Viitanen, M., Warpman, U., Johansson, M., Hellstrom-Lindahl, E., Bjurling, P., Fasth, K. J., Langstrom, B. & Windblad, B. (1992) Neurobiol. Aging 13, 747-758.
13. Nordberg, A. (1993) Acta Neurol. Scand. Suppl. 149, 62-65.
14. Said, S. I. & Mutt, V. (1988) Ann. N.Y. Acad. Sci. 527, 1-691.
15. Gozes, I. & Brenneman, D. E. (1989) Mol. Neurobiol. 3, 201-236.
16. Gozes, I. & Brenneman, D. E. (1993) J. Mol. Neurosci. 4, 1-9.
17. Brenneman, D. E. & Eiden, L. E. (1986) Proc. Natl. Acad. Sci. USA 83, 1159-1162.
18. Brenneman, D. E., Westbrook, G. L., Fitzgerald, S P., Ennist, D. L., Elkins, K. L., Ruff, M. R. & Pert, C. B. (1988) Nature (London) 335, 639-642.
19. Gozes, I., Shani, Y. & Rostene, W. H. (1987) Mol. Brain Res. 2, 137-148.
20. Baldino, F., Jr., Fitzpatrick-McElligott, S., Gozes, I. & Card, J. P. (1989) J. Mol. Neurosci. 1, 199-207.
21. Dussaillant, M., Sarrieau, A., Gozes, I., Berod, A. & Rostene, W. H. (1992) Neuroscience 50, 519-530.
22. Gozes, I., Shachter, P., Shani, Y. & Giladi, E. (1988) Neuroendocrinology 47, 27-31.
23. Glowa, J. R., Panlilio, L. V., Brenneman, D. E., Gozes, I., Fridkin, M. & Hill, J. M. (1992) Brain Res. 570, 49-53.
24. Gozes, I., Glowa, J., Brenneman, D. E., McCune, S. K., Lee, E. & Westphal, H. (1993) J. Mol. Neurosci. 4, 185-193.
25. Lundberg, J. M., Hedlund, B. & Bartfai, T. (1982) Nature (London) 295, 147-149.
26. Hedlund, B., Abens, J. & Bartfai, T. (1983) Science 220, 519-521.
27. Eckenstein, F. & Baughman, R. W. (1984) Nature (London) 309, 153-155.
28. Masuo, Y., Matsumoto, Y., Tokito, F., Tsuda, M. & Fujino, M. (1993) Brain Res. 611, 207-215.
29. Arai, H., Moroji, T. & Koska, K. (1984) Neurosci. Lett. 52, 73-78.
30. Gozes, I. & Fridkin, M. (1992) J. Clin. Invest. 90, 810-814.
31. Gozes, I. & Fridkin, M. (1993) in Peptide Chemistry 1992, ed. Yanaihara, N. (ESCOM, Leiden, The Netherlands), pp. 442-445.
32. Gozes, I., Reshef, A., Salah, D., Rubinraut, S. & Fridkin, M. (1994) Endocrinology 134, 2121-2125.
33. Forsythe, I. D. & Westbrook, G. L. (1988) J. Physiol. (London) 396, 515-533.
34. Gozes, I., McCune, S. K., Jacobson, L., Warren, D., Moody, T. W., Fridkin, M. & Brenneman, D. E. (1991) J. Pharmacol. Exp. Ther. 257, 959-966.
35. Romijn, H. J., Habets, A. M. M. C., Mud, M. T. & Wolters, P.S. (1982) Dev. Brain Res. 2, 583-589.
36. Lilling, G., Wollman, Y., Goldstein, M. N., Rubinraut, S., Fridkin, M., Brenneman, D. E. & Gozes, I. (1995) J. Mol. Neurosci. 4, 231-239.
37. Morris, R. G., Garrud, P., Rawlins, J. N. P. & O'Keefe, J. (1982) Nature (London) 297, 681-683.
38. Morris, R. G., Anderson, E., Lynch, G. S. & Baudry, M. (1986) Nature (London) 319, 774-776.
39. Moser, E., Moser, M.-B. & Andersen, P. (1993) J. Neurosci. 13, 3916-3923.
40. Yankner, B. A., Duffy, I. K. & Kirschner, D. A. (1990) Science 250, 279-282.
41. Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G. & Cotman, C. W. (1993) J. Neurosci. 13, 1676-1687.
42. Gozes, I., Lilling, G., Glazer, R., Ticher, A., Ashkenazi, I. E., Davidson, A., Rubinraut, S., Fridkin, M. & Brenneman, D. E. (1995) J. Pharmacol. Exp. Ther. 273, 161-167.
43. Christos, G. A. (1993) Med. Hypotheses 41, 435-439.
44. Prospero-Garcia, O., Jimenez-Anquiano, A. & Drucker-Colin R. (1993) Neuropsychopharmacology 8, 387-390.
45. Jimenez-Anquiano, A., Baez-Saldana, A. & Drucker-Colin, R. (1993) Brain Res. 631, 345-348.
46. Brenneman, D. E., Neale, E. A., Foster, G. A., d'Autremont, S. & Westbrook, G. L. (1987) J. Cell Biol. 104, 1603-1610.
47. Brenneman, D. E., Nicol, T., Warren, D. & Bowers, L. M. (1990) J. Neurosci. Res. 25, 386-394.
48. Fatatis, A., Holtzclaw, L. A., Avidor, R., Brenneman, D. E. & Russell, J. T. (1994) Proc. Natl. Acad. Sci. USA 91, 2036-2040.
49. Roses, A. D., Strittmatter, W. J., Pericak-Vance, M. A., Corder, E. H., Saunders, A. M. & Schmechel, D. E. (1994) Lancet 343, 1564-1565.